3rd Dec 2020 11:21
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) | Barclays PLC. | |
Company dealt in | WILLIS TOWERS WATSON PLC | |
Class of relevant security to which the | ORD | |
dealings being disclosed relate (Note 2) | ||
Date of dealing | 02 December 2020 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
Class of relevant security: | ORD |
|
| ||
Long | Short | ||||
Number | (%) | Number | (%) | ||
(1) | Relevant securities |
|
|
|
|
3,039,658 | 2.36% | 609,540 | 0.47% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
285,211 | 0.22% | 739,005 | 0.57% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
purchase/sell: | 0 | 0.00% | 0 | 0.00% | |
|
|
|
| ||
TOTAL: |
|
|
|
| |
3,324,869 | 2.58% | 1,348,545 | 1.05% | ||
|
|
|
|
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
|
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale | Number of relevant securities | Price per unit |
Purchase | 2 | 214.7200 USD |
Purchase | 13 | 212.7169 USD |
Purchase | 14 | 212.5019 USD |
Purchase | 15 | 213.1110 USD |
Purchase | 16 | 213.0581 USD |
Purchase | 18 | 212.9719 USD |
Purchase | 18 | 212.9716 USD |
Purchase | 20 | 213.1620 USD |
Purchase | 21 | 212.9478 USD |
Purchase | 21 | 215.2100 USD |
Purchase | 22 | 212.5909 USD |
Purchase | 23 | 213.0128 USD |
Purchase | 27 | 212.9100 USD |
Purchase | 31 | 213.1153 USD |
Purchase | 60 | 213.6800 USD |
Purchase | 92 | 212.4150 USD |
Purchase | 100 | 212.3700 USD |
Purchase | 100 | 213.9200 USD |
Purchase | 115 | 215.3223 USD |
Purchase | 120 | 215.2766 USD |
Purchase | 126 | 212.7595 USD |
Purchase | 141 | 212.4093 USD |
Purchase | 222 | 211.9675 USD |
Purchase | 230 | 212.5527 USD |
Purchase | 238 | 212.9391 USD |
Purchase | 239 | 213.6813 USD |
Purchase | 258 | 212.5341 USD |
Purchase | 267 | 215.2318 USD |
Purchase | 272 | 212.7394 USD |
Purchase | 288 | 213.0338 USD |
Purchase | 384 | 212.8770 USD |
Purchase | 396 | 213.5560 USD |
Purchase | 400 | 212.9316 USD |
Purchase | 416 | 212.8180 USD |
Purchase | 517 | 212.8305 USD |
Purchase | 517 | 215.3776 USD |
Purchase | 574 | 215.4842 USD |
Purchase | 685 | 212.5865 USD |
Purchase | 1,075 | 212.6502 USD |
Purchase | 1,171 | 215.2917 USD |
Purchase | 2,260 | 212.6221 USD |
Purchase | 4,106 | 212.6730 USD |
Purchase | 4,463 | 212.8202 USD |
Purchase | 4,565 | 212.5250 USD |
Purchase | 5,535 | 212.4900 USD |
Purchase | 15,662 | 212.9133 USD |
Sale | 1 | 214.5200 USD |
Sale | 1 | 212.5400 USD |
Sale | 1 | 215.2800 USD |
Sale | 3 | 213.7550 USD |
Sale | 7 | 212.3900 USD |
Sale | 7 | 212.9685 USD |
Sale | 9 | 212.7866 USD |
Sale | 10 | 212.9200 USD |
Sale | 72 | 215.0800 USD |
Sale | 123 | 212.5534 USD |
Sale | 132 | 212.2248 USD |
Sale | 200 | 214.1800 USD |
Sale | 201 | 212.5101 USD |
Sale | 210 | 215.3076 USD |
Sale | 393 | 212.5205 USD |
Sale | 476 | 212.9391 USD |
Sale | 478 | 212.9700 USD |
Sale | 685 | 212.5865 USD |
Sale | 1,049 | 213.3874 USD |
Sale | 1,669 | 212.4897 USD |
Sale | 2,376 | 212.7322 USD |
Sale | 2,785 | 215.3416 USD |
Sale | 2,797 | 212.9479 USD |
Sale | 3,420 | 212.6453 USD |
Sale | 4,288 | 212.6370 USD |
Sale | 5,957 | 212.4900 USD |
Sale | 6,000 | 212.7315 USD |
Sale | 12,932 | 212.8323 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
Is a Supplemental Form 8 (Open Positions) attached? | NO |
Date of disclosure: | 3 Dec 2020 |
Contact name: | Large Holdings Regulatory Operations |
Telephone number: | 020 3134 7213 |
If a connected EFM, name of offeree/offeror with which connected | |
If a connected EFM, state nature of connection |
View source version on businesswire.com: https://www.businesswire.com/news/home/20201203005456/en/
Copyright Business Wire 2020
Related Shares:
Barclays